Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.990
-0.060 (-1.97%)
At close: Jun 27, 2025, 4:00 PM
2.900
-0.090 (-3.01%)
After-hours: Jun 27, 2025, 5:35 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $111.53 million as of June 27, 2025. Its market cap has increased by 33.10% in one year.
Market Cap
111.53M
Enterprise Value
78.22M
1-Year Change
33.10%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $111.53M, a decrease of -21.29%. That is a compound annual growth rate of -9.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 111.53M | 38.57% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.90B |
| Johnson & Johnson | 365.41B |
| AbbVie | 328.89B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.64B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.76B |
| AstraZeneca | 216.45B |